InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (3 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
3
T+90 hit rate
38%
T+90 mean return
-5.5%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Castillo Kirsten, Director. Insider active across 3 companies, notably Ocugen, Inc.. Cumulatively, 13 filings have been published. Breakdown: 3 buys · 3 sells. Total volume traded: €834k. History available since 7 June 2021. The latest transaction was disclosed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations13 total
27,500 shares0Common StockSEC:0001808806-26-000002:0
15,000 shares@ US$6.2615.1% of flowClass A Common StockSEC:0001808806-25-000003:0
Ideal exit: 11 Aug 2026 (T+270)
5,000 shares@ US$6.275.0% of flowClass A Common StockSEC:0001808806-25-000003:1
Ideal exit: 14 Aug 2026 (T+270)
9,868 shares0Class A Common StockSEC:0001628280-25-028628:0
25,000 shares@ US$0.91393.7% of flowCommon StockSEC:0001062993-24-019706:0
Ideal exit: 19 Aug 2025 (T+270)
15,000 sharesClass A Common StockSEC:0001628280-24-027582:0
9,239 shares0Class A Common StockSEC:0001628280-24-026052:0
30,000 sharesClass A Common StockSEC:0001209191-23-045836:0
30,000 shares@ US$15.6979.9% of flowClass A Common StockSEC:0001209191-23-045836:1
36,583 sharesClass A Common StockSEC:0001209191-23-032577:0
42,000 shares@ US$0.281.9% of flowCommon StockSEC:0001062993-22-017866:0
15,000 shares@ US$15.000.046% mcap35.1% of flowCommon StockSEC:0001891015-21-000008:0
10,000 shares@ US$10.000.019% mcap14.9% of flowCommon StockSEC:0001808806-21-000001:0
13 of 13 declarations
About Castillo Kirsten
Kirsten Castillo is a Board Member at Ocugen, Inc. She brings her expertise in biotechnology and product development, contributing to the governance of the company. Her role includes overseeing strategic initiatives and evaluating growth opportunities. Kirsten plays an important role in guiding the company's decisions regarding treatments and health solutions.
